TheraVasc's Series A - II Round

TheraVasc raised a round of funding on April 16, 2012.

TheraVasc is a privately-held biotechnology company with offices in Louisiana, focused on the development of vascular therapies with decreased risks through the repositioning of drugs with known safet…

Articles about TheraVasc's Series A - II Round: